Universal Ibogaine advises further on application for Management Cease Trade Order
Impact Biomedical Inc(US:IBO) Thenewswire·2025-12-03 01:00Calgary, AB – December 2, 2025 – TheNewswire – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”), a life sciences company with a mission to research and deliver medicalized ibogaine-centered addiction care, advises of the following additional points related to its prior News Release of November 25, 2025 regarding its application to the Alberta Securities Commission (the “ASC”, the Company’s Principal Regulator) for a Management Cease Trade Order (“MCTO”): The Company is not currently subject to a ...